FOLD

#1387
Amicus Therapeutics, Inc
14.4550 USD
-0.03%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
14.4500
14.4600
Intervallo Annuale
8.6200
14.4800
Variazione giornaliera
-0.03%
Variazione Mensile
+0.59%
Variazione di 6 mesi
+66.92%
Variazione Annuale
+66.92%
Chiusura Precedente
14.4600
Apertura
14.4600
Bid
Ask
Minimo
14.4500
High
14.4600
Volume
67
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 4.5389 B
  • Employee 511
  • Founded 2002
  • CEO Bradley L Campbell
  • Website www.amicusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG000PLF6N0
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-158.22
Rapporto prezzo/fatturato
6.92

Amicus Therapeutics Inc

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

Notizie